Drug recall · January 19, 2022
Sufentanil Citrate Injection recall
Why: Subpotent Drug: Out of specification for assay at the 30-month stability timepoint.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sufentanil Citrate Injection, USP 100 mcg/2 mL (50 mcg/mL) for intravenous and epidural use, Rx only, 2 mL Ampule, Warning - May be habit forming, Preservative Free, Manufactured by Akorn, Inc. Lake Forest, IL 60045, NDC 17478-0050-02.
- Lots / codes
Lot # 031489A, Expiration 03/31/2022
- Quantity
- 31,510 ampules
- Company
- Akorn, Inc., Lake Forest, IL
- Distribution
- Nationwide in the USA
- Initiated
- January 5, 2022 · Voluntary: Firm initiated
- Classified
- January 27, 2022
- Reported
- January 19, 2022
- Ended
- September 17, 2022
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sufentanil
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.